This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
6 Nov 2019

Method Development, Verification & Validation of NDMA & other impurities

LCMS/MS [API & Finished Dosage Form]

Accuprec Research Labs Pvt. Ltdhas successfully doneMethod Development, Verification & Validation of NDMA impurities in Ranitidine through LCMS/MS [API & Finished Dosage Form] as per USFDA method.

Key Features of Developed Method:
LoD = 0.2 ppb
LoQ = 0.6 ppb
% Recovery = 99.47 %

We have also done method validation for other impurities: NDEA, NEIPA, NDIPA, NDBA & NMBA

Mentioned Companies
Accuprec Research Labs Pvt Ltd
View company profile